Updated: SDNY Decision Allows Drug Maker to Promote Off-Label Use | Practical Law
In a recent decision, the US District Court for the Southern District of New York granted a preliminary injunction against the Food and Drug Administration (FDA) allowing a drug manufacturer to promote an unapproved (off-label) use of a drug.